{
  "zip": "06824",
  "sector": "Healthcare",
  "fullTimeEmployees": 7,
  "longBusinessSummary": "Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.",
  "city": "Fairfield",
  "phone": "203-368-6044",
  "state": "CT",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.calmaretherapeutics.com",
  "maxAge": 1,
  "address1": "1375 Kings Highway East",
  "fax": "203-368-5399",
  "industry": "Medical Devices",
  "address2": "Suite 400",
  "previousClose": 0.08,
  "regularMarketOpen": 0.08,
  "twoHundredDayAverage": 0.07877698,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.08,
  "navPrice": null,
  "averageDailyVolume10Day": 3000,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.08,
  "fiftyDayAverage": 0.07121212,
  "trailingAnnualDividendRate": null,
  "open": 0.08,
  "averageVolume10days": 3000,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.625,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.08,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 2700,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 5953824,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 7406,
  "priceToSalesTrailing12Months": 5.2009273,
  "dayLow": 0.08,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 2700,
  "fiftyTwoWeekHigh": 0.2,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.03,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.08,
  "exchange": "PNK",
  "shortName": "CALMARE THERAPEUTICS INC",
  "longName": "Calmare Therapeutics Incorporated",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CTTC",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_311343",
  "uuid": "f5dceaaf-9905-39c6-8074-8d8a9f4f33e3",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 7.333,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -3.449,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 30376600,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.479,
  "sharesShort": 212630,
  "sharesPercentSharesOut": 0.0154,
  "fundFamily": null,
  "lastFiscalYearEnd": 1483142400,
  "heldPercentInstitutions": 0.06825,
  "netIncomeToCommon": -3828634,
  "trailingEps": -0.133,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1546214400,
  "mostRecentQuarter": 1483142400,
  "shortRatio": 3.99,
  "sharesShortPreviousMonthDate": 1279152000,
  "floatShares": 18206542,
  "enterpriseValue": 8395105,
  "threeYearAverageReturn": null,
  "lastSplitDate": 353635200,
  "lastSplitFactor": "3:2",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1281657600,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0156,
  "sharesShortPriorMonth": 175061,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.08,
  "logo_url": "https://logo.clearbit.com/calmaretherapeutics.com"
}